| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $249.2M | +2.9% | +25.0% |
| Cost of Revenue | $72.8M | +2.9% | +5.0% |
| Gross Profit | $176.3M | +2.9% | +35.7% |
| R&D Expense | $78.5M | +7.5% | +19.1% |
| SG&A Expense | $61.8M | -2.7% | +53.4% |
| Operating Income | -$42.2M | -21.4% | +4.1% |
| Pre-tax Income | -$38.9M | -22.2% | +15.5% |
| Income Tax | $601K | +65.1% | +49.9% |
| Net Income | -$39.5M | -22.7% | +14.9% |
| EPS (Basic) | -$0.42 | -20.0% | +75.9% |
| EPS (Diluted) | -$0.42 | -20.0% | +75.9% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $493.2M | +4.6% | +268.6% |
| Accounts Receivable | $52.5M | +1.1% | +27.3% |
| Current Assets | $644.0M | +3.4% | +155.0% |
| Total Assets | $1.82B | +1.8% | +23.7% |
| Current Liabilities | $155.6M | +12.2% | +11.2% |
| Long-term Debt | $103.6M |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $69.5M | — | — |
| Capital Expenditures | $4.0M | — | — |
| Investing Cash Flow | -$39.7M | — | — |
| Financing Cash Flow | $21.1M | — | — |
| Free Cash Flow | $65.5M | — | — |
| -40.5% |
| Total Liabilities | $311.7M | +5.8% | -16.6% |
| Stockholders' Equity | $1.50B | +1.0% | +360.9% |